Application | Comment | Organism |
---|---|---|
synthesis | the SbnCEF synthetases and decarboxylase SbnH are necessary and sufficient to produce staphyloferrin B in vitro in reactions containing component substrates L-2,3-diaminopropionic acid, citric acid and 2-oxoglutaric acid | Staphylococcus aureus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
citrate | Michaelis-Menten kinetics are observed at substrate concentrations as high as 30 mM citrate, pH 7.4, temperature not specified in the publication | Staphylococcus aureus | |
0.99 | - |
citrate | pH 7.4, temperature not specified in the publication | Staphylococcus aureus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
additional information | - |
enzyme exists as monomer and dimer, gel filtration | Staphylococcus aureus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + L-2,3-diaminopropanoate + citrate | Staphylococcus aureus | - |
AMP + diphosphate + 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate | - |
? | |
ATP + L-2,3-diaminopropanoate + citrate | Staphylococcus aureus NCTC 8325 | - |
AMP + diphosphate + 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | Q2G1M9 | - |
- |
Staphylococcus aureus NCTC 8325 | Q2G1M9 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + 1,2-diaminoethane + citrate | - |
Staphylococcus aureus | AMP + diphosphate + 2-[2-[(2-aminoethyl)amino]-2-oxoethyl]-2-hydroxybutandioate | - |
? | |
ATP + 1,2-diaminoethane + citrate | - |
Staphylococcus aureus NCTC 8325 | AMP + diphosphate + 2-[2-[(2-aminoethyl)amino]-2-oxoethyl]-2-hydroxybutandioate | - |
? | |
ATP + L-2,3-diaminopropanoate + citrate | - |
Staphylococcus aureus | AMP + diphosphate + 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate | - |
? | |
ATP + L-2,3-diaminopropanoate + citrate | - |
Staphylococcus aureus NCTC 8325 | AMP + diphosphate + 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | and monomer, 2 * 66000, calculated from sequence | Staphylococcus aureus |
monomer | and dimer, 1 * 66000, calculated from sequence | Staphylococcus aureus |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.268 | - |
citrate | pH 7.4, temperature not specified in the publication | Staphylococcus aureus |
Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|
Staphylococcus aureus | calculated from sequence | - |
5.5 |
General Information | Comment | Organism |
---|---|---|
physiological function | enzyme is involved in biosynthesis of staphyloferrin B. The SbnCEF synthetases and decarboxylase SbnH are necessary and sufficient to produce staphyloferrin B in vitro. SbnE initiates staphyloferrin B synthesis | Staphylococcus aureus |